Tenaya Therapeutics' Cash Burn: A Closer Look at its Cash Reserves and Growth Potential

Tenaya Therapeutics (NASDAQ:TNYA) has a cash runway of around 9 months, indicating a need to either reduce cash burn or replenish its cash. The company's cash burn has decreased by 23% over the last year, but the crucial factor is whether it will grow its business going forward. Tenaya Therapeutics can raise more cash through issuing new shares or taking on debt, but its ability to do so is crucial to sustaining its growth.